Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Emerg Infect Dis ; 25(5): 919-926, 2019 05.
Article in English | MEDLINE | ID: mdl-30681072

ABSTRACT

For safety, designated Select Agents in tissues must be inactivated and viability tested before the tissue undergoes further processing and analysis. In response to the shipping of samples of "inactivated" Bacillus anthracis that inadvertently contained live spores to nonregulated entities and partners worldwide, the Federal Register now mandates in-house validation of inactivation procedures and standardization of viability testing to detect live organisms in samples containing Select Agents that have undergone an inactivation process. We tested and validated formaldehyde and glutaraldehyde inactivation procedures for animal tissues infected with virulent B. anthracis, Burkholderia pseudomallei, Francisella tularensis, and Yersinia pestis. We confirmed that our fixation procedures for tissues containing these Tier 1 Select Agents resulted in complete inactivation and that our validated viability testing methods do not interfere with detection of live organisms. Institutions may use this work as a guide to develop and conduct their own testing to comply with the policy.


Subject(s)
Bacteria/drug effects , Disinfectants/pharmacology , Formaldehyde/pharmacology , Glutaral/pharmacology , Microbial Viability/drug effects , Animals , Guinea Pigs , Organ Specificity , Spores, Bacterial/drug effects , Time Factors
2.
PLoS One ; 13(11): e0208277, 2018.
Article in English | MEDLINE | ID: mdl-30500862

ABSTRACT

Mouse models have been essential to generate supporting data for the research of infectious diseases. Burkholderia pseudomallei, the etiological agent of melioidosis, has been studied using mouse models to investigate pathogenesis and efficacy of novel medical countermeasures to include both vaccines and therapeutics. Previous characterization of mouse models of melioidosis have demonstrated that BALB/c mice present with an acute infection, whereas C57BL/6 mice have shown a tendency to be more resistant to infection and may model chronic disease. In this study, either BALB/c or C57BL/6 mice were exposed to aerosolized human clinical isolates of B. pseudomallei. The bacterial strains included HBPUB10134a (virulent isolate from Thailand), MSHR5855 (virulent isolate from Australia), and 1106a (relatively attenuated isolate from Thailand). The LD50 values were calculated and serial sample collections were performed in order to examine the bacterial burdens in tissues, histopathological features of disease, and the immune response mounted by the mice after exposure to aerosolized B. pseudomallei. These data will be important when utilizing these models for testing novel medical countermeasures. Additionally, by comparing highly virulent strains with attenuated isolates, we hope to better understand the complex disease pathogenesis associated with this bacterium.


Subject(s)
Burkholderia pseudomallei/physiology , Melioidosis/pathology , Animals , Antibody Formation , Australia/epidemiology , Bronchi/immunology , Bronchi/microbiology , Bronchi/pathology , Burkholderia pseudomallei/pathogenicity , Cytokines/blood , Cytokines/immunology , Disease Models, Animal , Disease Progression , Female , Humans , Immunoglobulin G/blood , Immunoglobulin G/immunology , Melioidosis/blood , Melioidosis/epidemiology , Melioidosis/immunology , Mice, Inbred BALB C , Mice, Inbred C57BL , Thailand/epidemiology , Virulence
3.
Appl Environ Microbiol ; 84(12)2018 06 15.
Article in English | MEDLINE | ID: mdl-29654186

ABSTRACT

In 2015, a laboratory of the United States Department of Defense (DoD) inadvertently shipped preparations of gamma-irradiated spores of Bacillus anthracis that contained live spores. In response, a systematic evidence-based method for preparing, concentrating, irradiating, and verifying the inactivation of spore materials was developed. We demonstrate the consistency of spore preparations across multiple biological replicates and show that two different DoD institutions independently obtained comparable dose-inactivation curves for a monodisperse suspension of B. anthracis spores containing 3 × 1010 CFU. Spore preparations from three different institutions and three strain backgrounds yielded similar decimal reduction (D10) values and irradiation doses required to ensure sterility (DSAL) to the point at which the probability of detecting a viable spore is 10-6 Furthermore, spores of a genetically tagged strain of B. anthracis strain Sterne were used to show that high densities of dead spores suppress the recovery of viable spores. Together, we present an integrated method for preparing, irradiating, and verifying the inactivation of spores of B. anthracis for use as standard reagents for testing and evaluating detection and diagnostic devices and techniques.IMPORTANCE The inadvertent shipment by a U.S. Department of Defense (DoD) laboratory of live Bacillus anthracis (anthrax) spores to U.S. and international destinations revealed the need to standardize inactivation methods for materials derived from biological select agents and toxins (BSAT) and for the development of evidence-based methods to prevent the recurrence of such an event. Following a retrospective analysis of the procedures previously employed to generate inactivated B. anthracis spores, a study was commissioned by the DoD to provide data required to support the production of inactivated spores for the biodefense community. The results of this work are presented in this publication, which details the method by which spores can be prepared, irradiated, and tested, such that the chance of finding residual living spores in any given preparation is 1/1,000,000. These irradiated spores are used to test equipment and methods for the detection of agents of biological warfare and bioterrorism.


Subject(s)
Bacillus anthracis/radiation effects , Gamma Rays , Microbial Viability/radiation effects , Spores, Bacterial/radiation effects , Sterilization/methods , Bacillus anthracis/physiology , Microbiological Techniques/methods , Retrospective Studies , Spores, Bacterial/physiology
4.
Emerg Infect Dis ; 24(4)2018 04.
Article in English | MEDLINE | ID: mdl-29553922

ABSTRACT

The revelation in May 2015 of the shipment of γ irradiation-inactivated wild-type Bacillus anthracis spore preparations containing a small number of live spores raised concern about the safety and security of these materials. The finding also raised doubts about the validity of the protocols and procedures used to prepare them. Such inactivated reference materials were used as positive controls in assays to detect suspected B. anthracis in samples because live agent cannot be shipped for use in field settings, in improvement of currently deployed detection methods or development of new methods, or for quality assurance and training activities. Hence, risk-mitigated B. anthracis strains are needed to fulfill these requirements. We constructed a genetically inactivated or attenuated strain containing relevant molecular assay targets and tested to compare assay performance using this strain to the historical data obtained using irradiation-inactivated virulent spores.


Subject(s)
Anthrax/microbiology , Bacillus anthracis/physiology , Bacillus anthracis/radiation effects , Radiation , Spores, Bacterial/radiation effects , Animals , Bacillus anthracis/virology , Bacterial Toxins/genetics , Female , Gene Knockdown Techniques , Humans , Mice , Mutagenesis, Insertional , Plasmids/genetics , Recombination, Genetic , Reproducibility of Results , Virulence , Whole Genome Sequencing
5.
PLoS One ; 12(2): e0172627, 2017.
Article in English | MEDLINE | ID: mdl-28235018

ABSTRACT

Burkholderia pseudomallei, the etiologic agent of melioidosis, is a Gram negative bacterium designated as a Tier 1 threat. This bacterium is known to be endemic in Southeast Asia and Northern Australia and can infect humans and animals by several routes. Inhalational melioidosis has been associated with monsoonal rains in endemic areas and is also a significant concern in the biodefense community. There are currently no effective vaccines for B. pseudomallei and antibiotic treatment can be hampered by non-specific symptomology and also the high rate of naturally occurring antibiotic resistant strains. Well-characterized animal models will be essential when selecting novel medical countermeasures for evaluation prior to human clinical trials. Here, we further characterize differences between the responses of BALB/c and C57BL/6 mice when challenged with low doses of a low-passage and well-defined stock of B. pseudomallei K96243 via either intraperitoneal or aerosol routes of exposure. Before challenge, mice were implanted with a transponder to collect body temperature readings, and daily body weights were also recorded. Mice were euthanized on select days for pathological analyses and determination of the bacterial burden in selected tissues (blood, lungs, liver, and spleen). Additionally, spleen homogenate and sera samples were analyzed to better characterize the host immune response after infection with aerosolized bacteria. These clinical, pathological, and immunological data highlighted and confirmed important similarities and differences between these murine models and exposure routes.


Subject(s)
Burkholderia pseudomallei/immunology , Immunity, Innate , Liver/immunology , Lung/immunology , Melioidosis/immunology , Spleen/immunology , Administration, Inhalation , Animals , Bacterial Load , Body Temperature , Body Weight , Burkholderia pseudomallei/growth & development , Burkholderia pseudomallei/pathogenicity , Colony Count, Microbial , Cytokines/biosynthesis , Cytokines/immunology , Disease Models, Animal , Female , Granulocytes/immunology , Granulocytes/microbiology , Humans , Injections, Intraperitoneal , Liver/microbiology , Lung/microbiology , Lymphocyte Subsets/classification , Lymphocyte Subsets/immunology , Lymphocyte Subsets/microbiology , Melioidosis/microbiology , Melioidosis/pathology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Monocytes/immunology , Monocytes/microbiology , Species Specificity , Spleen/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL
...